Revolade 25 mg

REVOLADE 25 MG tablets contain eltrombopag olamine, a medication used to support platelet production. This oral treatment is commonly prescribed for conditions affecting blood cell counts.

REVOLADE 25 MG tablets are primarily used to increase platelet levels in individuals with certain blood disorders. Eltrombopag olamine works by stimulating the bone marrow to produce more platelets, which are essential for blood clotting. This medication is often considered when other treatments for low platelet counts have not been effective.

Common effects of REVOLADE 25 MG tablets may include nausea, dizziness, and fatigue. Some users might experience changes in liver function, so regular monitoring is advised. Always consult a healthcare provider for personalized advice.

REVOLADE 25 MG tablets should be handled with care, especially by individuals with liver conditions. It is important to follow the prescribed dosage and avoid self-adjustment. Pregnant or breastfeeding women should discuss potential risks with their healthcare provider.

REVOLADE 25 MG tablets may interact with certain medications, including those metabolized by the liver. Alcohol consumption should be limited, as it can affect liver function. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.